GGrantIndex
Sort

46,585 grants matching heart failure

Effect of Hospital-Cardiologist Integration on Clinical Practice, Healthcare Quality, and Medicare Spending

$784,231
Ali Moghtaderi · George Washington University · R01 · FY2020 · HL

Accelerating research to advance care for adults with congenital heart disease through development of validated scalable computational phenotypes

$784,220
Alexander R. Opotowsky · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · HL

Macrophages in Myocardial Infarction

$784,206
Nikolaos G Frangogiannis · Albert Einstein College Of Medicine · R01 · FY2025 · HL

Development of a Small, Durable, Hemocompatible Centrifugal Blood Pump for Children

$784,203
Choon-Sik Jhun · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2025 · HL

Generalizable prediction of medication adherence in heart failure

$784,179
Saul B. Blecker · New York University School Of Medicine · R01 · FY2023 · HL

Development of a Universal Bi-ventricular Replacement System for the Failing Heart

$784,152
Gerson Rosenberg · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2021 · HL

Smooth Muscle Mineralocorticoid Receptor in Vascular Aging and Hypertension

$784,123
Iris Z Jaffe · Tufts Medical Center · R01 · FY2019 · HL

CORE: HIGH-THROUGHPUT ANALYTICS

$784,056
Gary A Churchill · Jackson Laboratory · P50 · FY2011 · GM

Modeling of cell-specific LRP1 signaling in acute myocardial infarction

$784,046
Jeffrey J. Saucerman · University Of Virginia · R01 · FY2025 · HL

Modeling of cell-specific LRP1 signaling in acute myocardial infarction

$784,046
Jeffrey J. Saucerman · University Of Virginia · R01 · FY2024 · HL

Robust allograft tolerance in non-human primates

$783,995
Megan Sykes · Columbia University Health Sciences · R01 · FY2015 · OD

The KChIP2-JNK2 axis as a therapeutic target for sudden cardiac death

$783,860
Isabelle Deschenes · Ohio State University · R01 · FY2025 · HL

The KChIP2-JNK2 axis as a therapeutic target for sudden cardiac death

$783,860
Isabelle Deschenes · Ohio State University · R01 · FY2024 · HL

Demonstrating the Feasibility of Democratized Push-Button Autonomous Cardiac MRI exam in Community Family Health Centers (AutoCMR for FHC)

$783,801
Christopher T Nguyen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · HL

Cardiopulmonary Exercise MRI in Heart Failure with Preserved Ejection Fraction

$783,751
Reza Nezafat · Beth Israel Deaconess Medical Center · R01 · FY2021 · HL

Structure and function of voltage-gated calcium channels

$783,575
Daniel L Minor · University Of California, San Francisco · R01 · FY2020 · HL

Hypergen: Genetics of Left Ventricular Hypertrophy

$783,557
Donna K. Arnett · University Of Alabama At Birmingham · R01 · FY2010 · HL

Prospective Monitoring of Newly Approved Cardiovascular Drugs in Older Adults with Frailty

$783,556
Dae Hyun Kim · Brigham And Women'S Hospital · R01 · FY2019 · AG

Mechanisms of myocarditis and progressive cardiac fibrosis in chronic Trypanosoma cruzi infection.

$783,532
Kathryn Marie Jones · Baylor College Of Medicine · R01 · FY2022 · AI

Engineered Stem Cells for Cardiac Repair

$783,516
Michael Regnier · University Of Washington · R01 · FY2025 · HL

Clinical Trial to Slow the Progression of ADPKD

$783,144
Robert W Schrier · University Of Colorado Denver · U01 · FY2010 · DK

Clinical Trial to Slow the Progression of ADPKD

$783,144
Robert W Schrier · University Of Colorado Denver · U01 · FY2012 · DK

Clinical Trial to Slow the Progression of ADPKD

$783,144
Robert W Schrier · University Of Colorado Denver · U01 · FY2011 · DK

PERCUTANEOUS TREATMENT OF PERIPHERAL ARTERIAL OCCLUSIVE DISEASE WITH IMPLANTATION OF MULTIPLE, BALLOON-EXPANDABLE, DRUG-ELUTING BIORESORBABLE SCAFFOLDS (the Efemoral Vascular Scaffold System)

$783,064
Lewis Schwartz · Efemoral Medical, Inc. · R44 · FY2022 · HL

'Heart Failure in the Community: Multimorbidity and Outcomes'

$783,040
Veronique L Roger · Mayo Clinic Rochester · R01 · FY2015 · HL